Is this you? Create Your Porfile
Avatar

Y. Miyata

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Y. Miyata is active.

Explore More

Publication

Featured researches published by Y. Miyata.

European Urology Supplements | 2017

Effect of restricted salt intake on nocturia

M. Tomohiro; Y. Nakamura; T. Yasuda; K. Ohba; Y. Miyata; Hideki Sakai

European Urology Supplements | 2018

Pathological significance of thrombospondin-3 to -5 in patients with bladder cancer

K. Araki; Y. Miyata; Y. Nakamura; T. Yasuda; Y. Sagara; T. Matsuo; K. Ohba; Hideki Sakai

European Urology Supplements | 2018

4N1K-peptide derived from thrombospondins acts as a tumour suppressor in bladder cancer in vivo and in vitro: Potential therapeutic agents for intra-vesical therapy

Y. Miyata; A. Asai; T. Yasuda; Y. Nakamura; Y. Sagara; T. Matsuo; K. Ohba; Hideki Sakai

European Urology Supplements | 2018

Relationships between serum levels of acute phase reactants and molecular biological characteristics including intra-tumoural immune cells densities in renal cell carcinoma

Y. Miyata; Y. Sagara; Y. Nakamura; T. Yasuda; M. Tomohiro; K. Ohba; Y. Mochizuki; Hideki Sakai

European Urology Supplements | 2018

Anti-cancer effects of green tea consumption on malignant behavior up-regulated by smoking in patients with upper urinary tract cancer

Y. Saaara; Y. Miyata; Y. Nakamura; T. Yasuda; K. Araki; T. Matsuo; K. Ohba; Hideki Sakai

European Urology Supplements | 2017

Neoadjuvant hormonal therapy for patients with low risk prostate cancer stimulates lymphvessel invasion and shorten biochemical recurrence-free survival periods

Y. Miyata; Y. Mochizuki; Y. Shida; T. Matsuo; T. Hakariya; K. Ohba; B. Furusato; J. Fukuoka; Hideki Sakai

European Urology Supplements | 2017

Pathological significance and prognostic roles of c-Fes expression in bladder cancer differ depending on the grade

A. Asai; Y. Miyata; T. Yasuda; Y. Nakamura; T. Matsuo; K. Ohba; Hideki Sakai

European Urology Supplements | 2017

Pathological and prognostic significance of densities of CD57+ (natural killer cells), CD68+ (macrophage), and mast cells in renal cell carcinoma tissues

Y. Mochizuki; Y. Miyata; T. Yasuda; Y. Nakamura; T. Matsuo; K. Oba; Hideki Sakai

European Urology Supplements | 2017

Reduced expressions of 4N1K-peptide derived from thrombospondin-2 is associated with malignant aggressiveness and prognosis in bladder cancer

Y. Mochizuki; Y. Miyata; T. Yasuda; Y. Nakamura; T. Matsuo; K. Ohba; B. Furusato; J. Fukuoka; Hideki Sakai

European Urology Supplements | 2016

760 Alternative treatment with every other day dosing of sunitinib for patients with metastatic renal cell carcinoma: Efficacy and safety

K. Ohba; Y. Miyata; A. Asai; T. Matsuo; Hideki Sakai

Explore More

Collaboration

Dive into the Y. Miyata's collaboration.

Top Co-Authors
Avatar

Hideki Sakai

Nagasaki University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge